RASP OTC
Actavia Life Sciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -87.5%
3Y: -95.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.4M
52W Range0.0004-0.004
Volume20
Avg Volume19
Beta-6.96
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKeeren Shah
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2015-02-24
Websiterasna.com
5 Penn Plaza
New York City, NY 10001
US
New York City, NY 10001
US
646 396 4087
About Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Latest News
No recent news
Recent Insider Trades
No insider trades found